VYNE

VYNE Therapeutics Inc

Halal Rating :
Comfortable
See Details
Last Price $2.70 Last updated:
Market Cap -
7D Change -14.72%
1 Year Change -32.29%

Company Overview

Industries
  • Manufacturing
  • Pharmaceutical Products
  • Pharmaceutical Preparations
Exchange
Next Earnings Date

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2024 $121000.0 $13.21m - - 0.00% 0.00%
June 30, 2024 $198000.0 $10.59m - - 0.00% 0.00%
March 31, 2024 $98000.0 $7.48m - - 0.00% 0.00%

Company Impact

Help us evaluate VYNE Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Justification for our Halal Rating

Recent News & Updates